2Remsen LG,Trail PA,Hellstrom I,et al.Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model[J].Neurosurgery,2000,46(3):704.
5Hosokawa S, Tagawa T, Niki H, et al. Efficacy of immunoliposomes on cancer models in a cell - surface - antigen - density - dependent manner[J]. Br J Cancer,2003,89(8) :1545.
10Boone E,Vanden Berghe T,Van Loo G,et al. Structure/Function analysis of p55 tumor necrosis factor receptor and fas-associated death domain.Effect on necrosis in L929sA cells.J Biol Chem, 2000,275(48):37596
7Obeidat B S, Strickland J R, Vogt M L, et al. Effects of lo- coweed on serum swainsonine and selected serum constituents in sheep during acute and subacute oral/intraruminal exposure [J].J Anita Sci, 2005,83 : 466-477.
8Zhang J S, Liu Y X, Hu L X, et al. Preparation and charac- terization of SARS in-house reference anti serum [J]. Vaccine, 2005,23 : 5666-5669.
9Winkler T, Sharma H S, Gordh T, et al. Topical application ofdynorphin A (1 - 17) antiserum attenuates trauma induced al- terations in spinal cord evoked potentials, microvascular perme- ability disturbances, edema formation and cell injury [J]. Amino Acids, 2002, 23: 273-281.
10Wu H, Schwasinger E T, Hong J, et al. Pretreatment with an- tiserum against dynorphin, substance P, or cholecystokinin en- hances the morphine-produced anti-allodynia in the sciatic nerve ligated mice[J]. Neuroscience Letters, 2005,386: 46-51.
